Oxford/AstraZeneca One of the creators of the Covid jab has hit out at the West’s “embarrassment of funds” in vaccine supplies as he called on world leaders to do more to ensure that developing countries survive the next outbreak of the pandemic. to vaccinate their population during the phase.
in a paper published in science translation therapy In Wednesday’s journal, Oxford University Professor Dame Sarah Gilbert reiterated the mantra that “no one is safe until we are all safe” and urged rich countries to play their part in equitable distribution of vaccines.
Countries that are less economically developed have found fewer jobs than richer countries such as the UK and the US.
As of early September 2021, 41.5 percent of the world’s population had received at least one dose of the vaccine, yet only 1.9 percent of those in low-income countries, Prof Gilbert wrote in the letter, co-authored with Dr Richard Hatchett. author, chief executive of the Coalition for Pandemic Preparedness Innovations.
According to Our World in Data, 66 percent of people in the UK have been fully vaccinated, while more than half (55 percent) of the US population has received both jabs. On the opposite end of the spectrum, in Ethiopia, Nigeria and Tanzania, less than 3 percent of people have been vaccinated.
The letter said the vaccine doses that would be available each month “will provide opportunities to achieve this”. [equitable distribution] As long as all countries are ready to receive and distribute these life-saving medical products.”
“Ensuring that they can do so will be one of the most urgent challenges in the next phase of the COVID-19 pandemic,” it says.
“In many high-income countries, more than 50 percent of the population has received two doses of the vaccine. In high-income countries, the next questions are whether, or when, booster doses should be given and whether vaccination should be expanded to children in pursuit of herd immunity.
“Such expansion of use of COVID-19 vaccines by high-income countries would put additional pressure on global vaccine supplies and potentially increase inequalities in vaccine access between high-income countries and the rest of the world.”
The letter continues: “It is more important than ever that we do not forget the lives that can be saved by giving first and second doses to the most vulnerable populations around the world and that the global distribution of vaccines provides an opportunity to protect all of us. . Reducing the selection of further variants.”
However, the authors noted that, fortunately, the number of vaccines being produced has “markedly” increased and even warned that there could be the potential for an “embarrassment of funds” unless That no more is done to help low-income countries get infrastructure. place to offer more widespread vaccination.
Professors Gilbert and Dr Hatchett wrote, “The spread of authorized COVID-19 vaccines and their total supply is projected to increase rapidly, which has the potential to create an embarrassment of funds.”
“While the early stages of vaccine rollout resulted in intense competition for these doses and severe inequalities in their distribution as a result of constraints on the supply of a limited number of products, we can now imagine facing a very different problem in the coming months. in one whose supply volumes exceed the capacity to absorb and distribute the vaccine to the countries with the greatest outstanding needs.
“The new imperative for COVAX, and for international relief efforts in general, will be to support mass distribution to ensure that recipient countries are able to reach their coverage goals early.”
Prof Gilbert said: “It is encouraging to see that the supply of vaccines is becoming less of a problem, but no vaccine is effective until people are vaccinated.
Credit: www.independent.co.uk /